David Dimmock

After graduating from St George’s Hospital Medical School (University of London) in 1998, David undertook training in hospital-based pediatrics including NICU in the UK. He completed a US pediatric residency program in Phoenix. He then undertook Genetics and Clinical Metabolic Genetics fellowship training at Baylor College of Medicine (BCM) in Houston. He is board certified in Clinical Biochemical Genetics, Pediatrics, and Clinical Genetics. After a faculty appointment at BCM, he moved on to the Medical College of Wisconsin becoming an Associate Professor of Pediatrics and the Chair of the State of Wisconsin newborn screening metabolic disease subcommittee. In June 2016, he was part of the founding team for the Rady Children’s Institute for Genomic Medicine. In this role he oversaw pivotal studies evaluating the benefit of rapid genomic testing from the perspective of patients, parents, providers, and payors.

David is passionate about improving the standard of care for children and adults with inborn errors of metabolism. Over 20 years of clinical experience, his medical practice has become focused on the identification of rare disorders through newborn screening and advanced genomic techniques and treatment through preclinical through phase 4 studies.

He has been an invited advisor to the FDA, CDC, and the Institute of Medicine. In addition to substantive NIH grants, he has been the principal investigator on more than 20 clinical trials of novel therapeutics in rare metabolic diseases.